Medtronic plc. vs Johnson & Johnson — Stock Comparison
Q·Score Breakdown
7
Buy
Overall
7.1
Buy
Quality
Health
Growth
Valuation
Sentiment
MDT
Analysts see 35% upside to $108.00 consensus target.
JNJ
High-quality business with 26% return on equity and 22% profit margins.
⚠ earnings contracting 53% year-over-year.
Analyst Consensus
BUY
Target $108.00 (+34.5%)
25 analysts
BUY
Target $252.42 (+9.8%)
24 analysts
Fundamentals
MDT
JNJ
22.4×
Trailing P/E
26.6×
13.2×
Forward P/E
18.1×
13.0%
Profit Margin
21.8%
65.2%
Gross Margin
68.0%
9.4%
ROE
26.4%
8.7%
Revenue Growth
9.9%
-11.8%
Earnings Growth
-52.9%
0.76
Beta
0.33
—
Price / Book
—
$103.1B
Market Cap
$553.3B
$79 – $106
52-Week Range
$146 – $252
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load.